Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2022 Earnings Call Transcript

Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2022 Earnings Call Transcript May 18, 2023

Operator: Good morning, and welcome to the Altamira Therapeutics 2022 Results Conference Call. On today’s call are Thomas Meyer, Altamira’s Founder, Chairman and Chief Executive Officer; and Covadonga Pañeda, Altamira’s Chief Operating Officer. Earlier today, Altamira issued a news release with the full year 2022 financial results as well as a comprehensive business update. The release is available...